Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R21CA261458 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
The present study is a pilot randomized controlled trial (RCT) that seeks to test the feasibility, acceptability, process outcomes, and exploratory outcomes of a newly integrated, app-based smoking cessation treatment (SiS-H, which stands for "Smiling instead of Smoking for people with HIV") for people with HIV who smoke. This treatment will be compared to onboarding to the National Cancer Institute's smartphone app "QuitGuide" (QG). Persons with HIV who smoke and are engaged in HIV clinical care (n=64) will be randomized (1:1) to smoking cessation support via SiS-H vs. "QuitGuide".
The team recently developed an mHealth intervention that integrates (1) the "Smiling instead of Smoking" (SiS) app, a conceptually-grounded, iteratively developed smoking cessation smartphone app, (2) a successful face-to-face smoking cessation treatment for smokers with HIV, called QUIT, and (3) Life Steps, an efficacious brief intervention to promote adaptive engagement in HIV care. The new integrated treatment emphasizes protecting the experience of positive emotions among smokers with HIV as they navigate the process of quitting smoking and supports smoking self-efficacy by engaging participants in app-based activities. Guidance and support for engaging with the app are provided through two face-to-face sessions.
The present study is a pilot randomized controlled trial (RCT) that seeks to test the feasibility, acceptability, process outcomes and exploratory outcomes of this new treatment, called SiS-H, compared to onboarding to the National Cancer Institute's smartphone app "QuitGuide" (QG). Smokers with HIV engaged in HIV clinical care (n=64) will be randomized (1:1) to smoking cessation support via SiS-H vs. the National Cancer Institute's smartphone app "QuitGuide" (QG).
Smoking cessation support will last 8 weeks and will consist of face-to-face interactions with study staff about navigating their assigned smoking cessation app and brief smoking cessation information. Participants will be offered nicotine replacement patches but will not be required to use them.
Study assessments will consist of online surveys (baseline, 2, 6, and 12 weeks post-quit), and biochemical tests of smoking status (baseline, 12 weeks post-quit). Data will be extracted from the medical record, with participants' permission.
The aims of the study are:
Below are specifics on the Specific Aims of this study, and the investigators' hypotheses:
Specific Aim 1: In this pilot randomized-controlled trial, the investigators will test the feasibility and acceptability of the SiS-H integrated treatment to support people with HIV in quitting smoking.
Feasibility (primary outcome): App use of the assigned app, as measured by the number of days participants used the app during the treatment period (8 weeks) will be significantly higher in SiS-H compared to QG. App use will be calculated based on passively collected app usage data.
Feasibility (secondary outcomes): The investigators hypothesize that SiS-H treatment will be feasible, as measured in the following ways:
Acceptability (secondary outcomes): The investigators hypothesize that SiS-H treatment will be acceptable (i.e., equal or higher scores compared to the control group), as measured at treatment end in the following ways:
Specific Aim 2: In this pilot RCT, the investigators will test the efficacy of the integrated SiS-H treatment to have a positive impact on variables relevant to the process of quitting smoking. Specifically, the investigators hypothesize outcomes will be better for the SiS-H group compared to the QG group at the end of treatment on the following measures:
Exploratory Aim 3: Although not statistically powered, the investigators will examine differences in 30-day point prevalence abstinence (biologically verified), other smoking outcomes, and 30-day self-reported ART adherence, as measured by the Medication Adherence scale, between both app groups.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Smiling instead of Smoking - HIV | Experimental | Participants will be onboarded to the smartphone app "Smiling instead of Smoking - HIV" (SiS-H), and will be asked to use it for 8 weeks while they quit smoking. |
|
| QuitGuide | Active Comparator | Participants will be onboarded to the smartphone app "QuitGuide" (QG), and will be asked to use it for 8 weeks while they quit smoking. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Smiling instead of Smoking - HIV | Behavioral | Participants will be onboarded to the smartphone app "Smiling instead of Smoking - HIV" (SiS-H) and will be asked to complete the integrated SiS-H program while they quit smoking. The integrated SiS-H treatment consists of: (1) face-to-face onboarding to the SiS-H app, (2) one face-to-face session discussing app usage and antiretroviral therapy (ART) adherence (Life Steps), with direct linkage to tools in the app supporting ART adherence, and (3) an 8-week course of the SiS-H app. The SiS-H app is a smoking cessation app that uses a positive psychology framework in conjunction with the US Clinical Practice Guidelines for smoking cessation to guide participants through the process of quitting smoking. |
| Measure | Description | Time Frame |
|---|---|---|
| App Usage | Number of days participants used the assigned app during the prescribed period of app use (i.e., 8 weeks for both apps). App usage is passively recorded by the app, which time-stamps every interaction with the app. | Continuously logged in the app from baseline (2 weeks pre-quit) to end of treatment (6 weeks post-quit). |
| Measure | Description | Time Frame |
|---|---|---|
| Time Spent Applying Content | Time spent applying content will be measured with the self-report item: "During the past week, how much time did you spend applying or contemplating the content of the [Smiling Instead of Smoking app / QuitGuide app (logic-branched by treatment group)]? ______________ (in minutes, total for the week)"). | Measured at week 4 (2 weeks post-quit) and week 8 (6-weeks post-quit) |
| Measure | Description | Time Frame |
|---|---|---|
| 30-day Point Prevalence Abstinence (PPA) - Self-reported | Participants will be asked to report whether they were abstinent some cigarette smoking during the last 30 days (yes vs. no). Missing data will be interpreted as smoking. | Measured at week 8 (6-weeks post-quit) |
| 30-day Point Prevalence Abstinence (PPA) - Biochemically Verified |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bettina Hoeppner, PhD, MS | Massachusetts General Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Behavioral Medicine Program (BMED) | Boston | Massachusetts | 02114 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| Background | Brooke, J. (1996). SUS: A 'quick and dirty' usability scale. In P. W. Jordan, B. Thomas, I. L. McClelland, & B. Weerdmeester (Eds.), Usability evaluation in industry (1st ed., Vol. 189, pp. 4-7). CRC Press. | ||
| 11260806 | Background | Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001 Feb;3(1):7-16. doi: 10.1080/14622200020032051. | |
| 10946439 |
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Smiling Instead of Smoking - HIV | Participants will be onboarded to the smartphone app "Smiling instead of Smoking - HIV" (SiS-H), and will be asked to use it for 8 weeks while they quit smoking. Smiling instead of Smoking - HIV: Participants will be onboarded to the smartphone app "Smiling instead of Smoking - HIV" (SiS-H) and will be asked to complete the integrated SiS-H program while they quit smoking. The integrated SiS-H treatment consists of: (1) face-to-face onboarding to the SiS-H app, (2) one face-to-face session discussing app usage and antiretroviral therapy (ART) adherence (Life Steps), with direct linkage to tools in the app supporting ART adherence, and (3) an 8-week course of the SiS-H app. The SiS-H app is a smoking cessation app that uses a positive psychology framework in conjunction with the US Clinical Practice Guidelines for smoking cessation to guide participants through the process of quitting smoking. |
| FG001 | QuitGuide | Participants will be onboarded to the smartphone app "QuitGuide" (QG), and will be asked to use it for 8 weeks while they quit smoking. QuitGuide: Participants will be onboarded to the NCI smartphone app QuitGuide(QG) and will be asked to use it for 8 weeks to support them in quitting smoking. The QuitGuide app follows the US Clinical Practice Guidelines. The app is freely available on NCI's Smokefree.gov website, which is a recommended resource for treating smokers in the healthcare setting. The QuitGuide app is frequently used as a comparison app in smartphone app smoking cessation studies. It asks participants to set a quit day, track their mood and cravings, and log their cigarettes. It provides app users with guidance on quitting (i.e., "Learn to Quit" information), offers strategies to counter smoking triggers, and allows users to set reminders to stay smoke free (time and location based). |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 4 (2 Weeks Post-quit) |
|
| |||||||||||||||||||||
| Week 8 Survey (6 Weeks Post-quit) |
| ||||||||||||||||||||||
| Follow-up (20 Weeks Post-quit) |
|
All randomized and starting study procedures (n=66; see Participant flow pre-assignment details).
Some measures had missing data.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Smiling Instead of Smoking - HIV | Participants were onboarded to the smartphone app "Smiling instead of Smoking - HIV" (SiS-H), and asked to use it for 8 weeks while they quit smoking. Smiling instead of Smoking - HIV: Participants were onboarded to the smartphone app "Smiling instead of Smoking - HIV" (SiS-H) and asked to complete the integrated SiS-H program while they quit smoking. The integrated SiS-H treatment consists of: (1) face-to-face onboarding to the SiS-H app, (2) one face-to-face session discussing app usage and antiretroviral therapy (ART) adherence (Life Steps), with direct linkage to tools in the app supporting ART adherence, and (3) an 8-week course of the SiS-H app. The SiS-H app is a smoking cessation app that uses a positive psychology framework in conjunction with the US Clinical Practice Guidelines for smoking cessation to guide participants through the process of quitting smoking. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | App Usage | Number of days participants used the assigned app during the prescribed period of app use (i.e., 8 weeks for both apps). App usage is passively recorded by the app, which time-stamps every interaction with the app. | All participants randomized to either of the app treatment groups (SiS or QG). | Posted | Mean | Standard Deviation | number of days of app use | Continuously logged in the app from baseline (2 weeks pre-quit) to end of treatment (6 weeks post-quit). |
|
Adverse event data could be reported during the entire period of a participant's study participation (i.e., up to 3 months).
Adverse events were not assessed systematically. However, they could be reported by spontaneous self-report by the participants at any point during the study.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Smiling Instead of Smoking - HIV | Participants will be onboarded to the smartphone app "Smiling instead of Smoking - HIV" (SiS-H), and will be asked to use it for 8 weeks while they quit smoking. Smiling instead of Smoking - HIV: Participants will be onboarded to the smartphone app "Smiling instead of Smoking - HIV" (SiS-H) and will be asked to complete the integrated SiS-H program while they quit smoking. The integrated SiS-H treatment consists of: (1) face-to-face onboarding to the SiS-H app, (2) one face-to-face session discussing app usage and antiretroviral therapy (ART) adherence (Life Steps), with direct linkage to tools in the app supporting ART adherence, and (3) an 8-week course of the SiS-H app. The SiS-H app is a smoking cessation app that uses a positive psychology framework in conjunction with the US Clinical Practice Guidelines for smoking cessation to guide participants through the process of quitting smoking. |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Bettina B. Hoeppner, Ph.D., MS | Health through Flourishing Program, Department of Psychiatry, Massachusetts General Hospital | (617) 643-1988 | bhoeppner@mgh.harvard.edu |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Sep 15, 2025 | Apr 10, 2026 | Prot_SAP_001.pdf |
| ICF | No | No | Yes | Informed Consent Form | Oct 1, 2025 | Apr 9, 2026 | ICF_002.pdf |
Not provided
| ID | Term |
|---|---|
| D016540 | Smoking Cessation |
| D012907 | Smoking |
| ID | Term |
|---|---|
| D015438 | Health Behavior |
| D001519 | Behavior |
Not provided
Not provided
2-group pilot randomized controlled trial
Not provided
Not provided
Not provided
Not provided
|
|
| QuitGuide | Behavioral | Participants will be onboarded to the NCI smartphone app QuitGuide(QG) and will be asked to use it for 8 weeks to support them in quitting smoking. The QuitGuide app follows the US Clinical Practice Guidelines. The app is freely available on NCI's Smokefree.gov website, which is a recommended resource for treating smokers in the healthcare setting. The QuitGuide app is frequently used as a comparison app in smartphone app smoking cessation studies. It asks participants to set a quit day, track their mood and cravings, and log their cigarettes. It provides app users with guidance on quitting (i.e., "Learn to Quit" information), offers strategies to counter smoking triggers, and allows users to set reminders to stay smoke free (time and location based). |
|
|
| Expected App Usage | A percentage based on the categorical re-coding of the actual app usage, measured in days, where YES indicates that participants used the app at least once during 6 out of the 8 weeks of the prescribed treatment weeks, and NO indicates that participants used the app less often. | Assessed at end of treatment (6 weeks post-quit) |
| Use of Smoking Cessation Strategies | Assessed using an 8-item measure in which participants rate the extent to which they agree or disagree with statements about the smoking cessation support they received and the things they did while quitting (5-point Likert scale, 1=strongly disagree, 5=strongly agree, e.g., "I used techniques to help me relax"). Higher scores indicate greater use of smoking cessation strategies. | Assessed at end of treatment (6 weeks post-quit) |
| Satisfaction With Smoking Cessation Support | As measured using the Client Satisfaction Scale (CSQ-8), an 8-item multiple choice measure that will be used to assess participants' satisfaction with the smoking cessation support they receive (e.g., "How satisfied are you with the amount of help you received?"). Scores are summed across items and range from 8 to 32, with higher scores indicating greater satisfaction. | Assessed at end of treatment (6 weeks post-quit) |
| App Usability Rating, System Usability Scale (SUS) | As assessed via the System Usability Scale (SUS), a ten-item attitude scale giving a global view of subjective assessments of usability, adapted to include language specific to the smoking app (e.g., "I found the smoking app unnecessarily complex" 5-point Likert: 1 = strongly disagree, 5 = strongly agree). Scale scores range from 0 to 100 with greater scores indicating a more favorable perception of usability of the app. | Assessed at end of treatment (6 weeks post-quit) |
| User Mobile Application Rating (uMARS) | User app ratings will be assessed using the Mobile Application Rating Scale user version (uMARS). The uMARS is a self-report form with 26 items that assess participants' evaluations of various app features. Dimensions of this measure include engagement (5 items), functionality (4 items), aesthetics (3 items), information quality (4 items), app subjectivity quality (4 items), and perceived impact (6 items). Items are rated on differently worded 5-point Likert scales ranging from 1 (Inadequate) to 5 (Excellent). An overall app rating score can be calculated as the mean score of the first 16 questions (range of 1-5), with higher scores meaning higher overall perceived app quality. | Assessed at end of treatment (6 weeks post-quit) |
| Smoking Self-Efficacy Questionnaire (SEQ-12) | The Smoking Self-Efficacy Questionnaire (SEQ-12) is a two-dimensional 12-item self-report scale measuring a person's confidence in his or her ability to abstain from smoking when facing internal stimuli (e.g. feeling depressed) and external stimuli (e.g. being with smokers) on a 0-100 slider scale (i.e., 0=not at all confident that I can refrain; 100=extremely confident that I can refrain). Scale scores are created by mean scoring across items and range from 0 to 100. Higher scores indicate greater self-efficacy to abstain from smoking. | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
| Positive Affect - Positive and Negative Affect Schedule (PANAS) | Positive affect will be measured using the Positive and Negative Affect Schedule (PANAS). This 20-item scale asks participants to indicate how they felt in the past week, using a 5-point Likert scale ranging from 1="very slightly or not at all" to 5="extremely." Scores for 10 positive words and 10 negative words will be summed separately and will be reported as mean scores (not scale totals) ranging from 1-5, with lower scores indicating low (positive or negative) affect and higher scores indicating high (positive or negative) affect. The 10 items for POSITIVE (PA) affect are attentive, interested, alert, excited, enthusiastic, inspired, proud, determined, strong, and active. | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
| Negative Affect - Positive and Negative Affect Schedule (PANAS) | Negative affect will be measured using the Positive and Negative Affect Schedule (PANAS). This 20-item scale asks participants to indicate how they felt in the past week, using a 5-point Likert scale ranging from 1="very slightly or not at all" to 5="extremely." Scores for 10 positive words and 10 negative words will be summed separately and will be reported as mean scores (not scale totals) ranging from 1-5, with lower scores indicating low (positive or negative) affect and higher scores indicating high (positive or negative) affect. The 10 items for NEGATIVE (NA) affect are distressed, upset, hostile, irritable, scared, afraid, ashamed, guilty, nervous, and jittery. | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
| Brief Questionnaire of Smoking Urges (QSU) | Smoking urges will be assessed using the Questionnaire of Smoking Urges. This 10-item scale assesses overall nicotine dependence, craving, and smoking withdrawal symptoms. Items will be rated on a 7-point Likert-scale ranging from 1=Strongly disagree to 7=Strongly agree. We will present the mean instead of total scores for ease in interpretation, so that scale scores can range from 1.0 to 7.0, with higher scores indicating greater smoking urges. | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
| Attitudes Towards Smoking Scale (ATS) - Adverse Effects of Smoking Sub-scale | Smoking attitudes will be assessed using the Attitudes Towards Smoking Scale (ATS-18). The 18-item self-report ATS-18 measures attitudes towards smoking in current and former cigarette smokers. It is rated on a 5-point Likert scale, from 1="strongly disagree" to 5="strongly agree.". The ATS-18 has 3 sub-scales: Adverse effects of smoking (items 1-10), psychoactive benefits of smoking (items 11-14), and pleasure of smoking (items 15-18). To score, all items per sub-scale will be averaged to obtain a mean score within each sub-scale. For each sub-scale, higher scores indicate greater agreement with the specific attitude towards smoking. | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
| Attitudes Towards Smoking Scale (ATS) - Psychoactive Benefits of Smoking Sub-scale | Smoking attitudes will be assessed using the Attitudes Towards Smoking Scale (ATS-18). The 18-item self-report ATS-18 measures attitudes towards smoking in current and former cigarette smokers. It is rated on a 5-point Likert scale, from 1="strongly disagree" to 5="strongly agree.". The ATS-18 has 3 sub-scales: Adverse effects of smoking (items 1-10), psychoactive benefits of smoking (items 11-14), and pleasure of smoking (items 15-18). To score, all items per sub-scale will be averaged to obtain a mean score within each sub-scale. For each sub-scale, higher scores indicate greater agreement with the specific attitude towards smoking. | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
| Attitudes Towards Smoking Scale (ATS) - Pleasure of Smoking Sub-scale | Smoking attitudes will be assessed using the Attitudes Towards Smoking Scale (ATS-18). The 18-item self-report ATS-18 measures attitudes towards smoking in current and former cigarette smokers. It is rated on a 5-point Likert scale, from 1="strongly disagree" to 5="strongly agree.". The ATS-18 has 3 sub-scales: Adverse effects of smoking (items 1-10), psychoactive benefits of smoking (items 11-14), and pleasure of smoking (items 15-18). To score, all items per sub-scale will be averaged to obtain a mean score within each sub-scale. For each sub-scale, higher scores indicate greater agreement with the specific attitude towards smoking. | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
| Decisional Balance Inventory (DBI) for Smoking - Negative Expectancies Sub-scale | Negative smoking expectancies will be assessed using the Decisional Balance Inventory (DBI) for Smoking Short Form. This 6-item form assesses the personal importance people place on positive and negative smoking expectancies. Items are rated on slider scales ranging from 0="not at all important" to 100="extremely important." Two sub-scale mean scores will be calculated: positive expectancies (3 items), and negative smoking expectancies (3 items). On both scales, higher scores indicate a greater importance of the smoking expectancies (positive or negative). | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
| Decisional Balance Inventory (DBI) for Smoking - Positive Expectancies Subscale | Positive smoking expectancies will be assessed using the Decisional Balance Inventory (DBI) for Smoking Short Form. This 6-item form assesses the personal importance people place on positive and negative smoking expectancies. Items are rated on slider scales ranging from 0="not at all important" to 100="extremely important." Two sub-scale mean scores will be calculated: positive expectancies (3 items), and negative smoking expectancies (3 items). On both scales, higher scores indicate a greater importance of the smoking expectancies (positive or negative). | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
| Modified Version of the Twenty Statements Test | The depth of the thought-action repertoire will be assessed using a modified version of the Open-Ended Twenty Statements Test (MOETST). The original MOETST usually starts by evoking an emotion, asks participants to name the emotion they experienced and keep it in mind, and then list all the things they would like to do 'right now'. Instead of using emotion inductions, we will ask participants to think of their upcoming quit date (at baseline) or when last using their assigned app treatment, and then fill out as many action statements as they can think of (limited to a maximum of 20) with the prompt "Instead of smoking at that moment, I could have ....". The number of actions will be summed to produce a thought-action repertoire score with a range of 0-20, with higher scores indicating a richer thought-action repertoire. | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
Participants will provide breath samples for expired carbon monoxide (CO; cutoff value of < 5 ppm). For CO-confirmed stated abstinence of 7 days or longer, abstinence will be verified by saliva cotinine using the NicAlert or similar test strip (based on availability; we will use test strips detecting 30ng of cotinine, where the test strip will indicate 'smoking' if the saliva content exceeds 30ng). This information will be combined with the self-reported abstinence data; reports of smoking abstinence that conflict with biochemical verification will be overridden with smoking status YES. |
| Measured at baseline and week 20 (3 months after end of treatment) |
| HIV Medication Adherence | HIV medication will be assessed with a 3-item medication adherence questionnaire. The three items ask about the number of days on which participants missed doses, the number of days when participants did not take medication as directed, and how well they followed directions. The answer options will be linearly transformed to 0-100 scales, averaged, and will generate a score between 0 and 100, with 0 being the lowest adherence and 100 being the highest adherence. | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
| Background |
| Etter JF, Bergman MM, Humair JP, Perneger TV. Development and validation of a scale measuring self-efficacy of current and former smokers. Addiction. 2000 Jun;95(6):901-13. doi: 10.1046/j.1360-0443.2000.9569017.x. |
| 10829336 | Background | Etter JF, Humair JP, Bergman MM, Perneger TV. Development and validation of the Attitudes Towards Smoking Scale (ATS-18). Addiction. 2000 Apr;95(4):613-25. doi: 10.1046/j.1360-0443.2000.95461312.x. |
| 21852891 | Background | Fredrickson BL, Branigan C. Positive emotions broaden the scope of attention and thought-action repertoires. Cogn Emot. 2005 May 1;19(3):313-332. doi: 10.1080/02699930441000238. |
| 10245370 | Background | Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197-207. doi: 10.1016/0149-7189(79)90094-6. No abstract available. |
| 27287964 | Background | Stoyanov SR, Hides L, Kavanagh DJ, Wilson H. Development and Validation of the User Version of the Mobile Application Rating Scale (uMARS). JMIR Mhealth Uhealth. 2016 Jun 10;4(2):e72. doi: 10.2196/mhealth.5849. |
| 15219341 | Background | Ward RM, Velicer WF, Rossi JS, Fava JL, Prochaska JO. Factorial invariance and internal consistency for the decisional balance inventory--short form. Addict Behav. 2004 Jul;29(5):953-8. doi: 10.1016/j.addbeh.2004.02.042. |
| 3397865 | Background | Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063. |
| 27098408 | Background | Wilson IB, Lee Y, Michaud J, Fowler FJ Jr, Rogers WH. Validation of a New Three-Item Self-Report Measure for Medication Adherence. AIDS Behav. 2016 Nov;20(11):2700-2708. doi: 10.1007/s10461-016-1406-x. |
| NOT COMPLETED |
|
|
| NOT COMPLETED |
|
|
| BG001 | QuitGuide | Participants were onboarded to the smartphone app "QuitGuide" (QG), and asked to use it for 8 weeks while they quit smoking. QuitGuide: Participants were onboarded to the NCI smartphone app QuitGuide(QG) and asked to use it for 8 weeks to support them in quitting smoking. The QuitGuide app follows the US Clinical Practice Guidelines. The app is freely available on NCI's Smokefree.gov website, which is a recommended resource for treating smokers in the healthcare setting. The QuitGuide app is frequently used as a comparison app in smartphone app smoking cessation studies. It asks participants to set a quit day, track their mood and cravings, and log their cigarettes. It provides app users with guidance on quitting (i.e., "Learn to Quit" information), offers strategies to counter smoking triggers, and allows users to set reminders to stay smoke free (time and location based). |
| BG002 | Total | Total of all reporting groups |
| Years |
|
| Sex/Gender, Customized | Count of Participants | Participants |
|
| Race (NIH/OMB) | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Highest level of education completed | Data was collected via self-report in pre-specified categories. | Count of Participants | Participants |
|
| Employment | Collected via self-report with pre-specified categories. | Count of Participants | Participants |
|
| Household Income | Collected via self-report with pre-specified categories. | Count of Participants | Participants |
|
| Rurality | Collected via self-report with pre-specified categories. | Count of Participants | Participants |
|
| Number of days smoked in past 30 days | One participant missed one or more items on the scale. | Mean | Standard Deviation | Number of days |
|
| Cigarettes per smoking day | Two participants had missing data for scale scores. | Mean | Standard Deviation | Cigarettes per day |
|
| Fagerstrom Test for Nicotine Dependence, total score | The Fagerström Test for Nicotine Dependence (FTND) is a standard instrument for assessing the intensity of physical addiction to nicotine. The test contains six items that evaluate the quantity of cigarette consumption, the compulsion to use, and dependence. In scoring the Fagerstrom Test for Nicotine Dependence, yes/no items are scored from 0 to 1 and multiple-choice items are scored from 0 to 3. The items are summed to yield a total score of 0-10.The higher the total Fagerström score, the more intense is the patient's physical dependence on nicotine. | Mean | Standard Deviation | Units on a scale |
|
| Ever smoked daily? | Count of Participants | Participants |
|
| Ever tried to quit smoking before | Collected via self-report with pre-specified categories. | Count of Participants | Participants |
|
| Ever used electronic cigarettes | Collected via self-report with pre-specified categories. | Count of Participants | Participants |
|
| Currently uses electronic cigarettes | Count of Participants | Participants |
|
| Patient Health Questionnaire for Depression | The Patient Health Questionnaire for Depression (PHQ-8) is an 8-item measure used to assess the levels of depression within participants over the prior 2-week period. For example, "Feeling down, depressed, or hopeless," participants answer on a scale from 0 to 1 day = "Not at all," to 12 to 14 days = "Nearly every day." Scores of 3-5, 6-8, and 9-12 represent mild, moderate, and severe depression respectively | Mean | Standard Deviation | Units on a scale |
|
| Generalized Anxiety Disorder screener | The Generalized Anxiety Disorder 7-item (GAD-7) scale is an easy to perform initial screening tool for generalized anxiety disorder. Items are score on 4-point Likert scales ranging from "Not at all" to"Nearly every day". GAD-7 total scores range from 0 to 21, with higher values indicating greater depression severity. | Mean | Standard Deviation | Units on a scale. |
|
| UCLA Three-Item Loneliness Scale (ULS-3) | The UCLA Three-Item Loneliness Scale asks respondents to indicate how often they experience feelings of loneliness across three items, using a 3-point response scale ranging from 1 ("Hardly ever") to 3 ("Often"). Total scores are calculated by summing responses across the three items, yielding scores from 3 to 9, with higher scores indicating greater severity of loneliness. | Mean | Standard Deviation | Units on a scale. |
|
| Ever told they had a mental health or psychological condition | Asked as a Yes/No question. | Count of Participants | Participants |
|
| Alcohol Use Disorders Identification Test Consumption (AUDIT-C) Screening Questionnaire | The Alcohol Use Screening is a 3-item measure assessing a risky drinking and alcohol use disorder. Participants are asked to indicate how often they drink and if they indicate drinking how many drinks they consume on average. Sum of scores for the 3 questions resulting in possible AUDIT-C scores from 0 to 12, with higher scores indicating a greater likelihood of risky drinking and alcohol use disorder. The AUDIT-C screening thresholds for alcohol misuse were ≥ 4 in men ≥ 3 in women in primary care contexts. | One participant missed one or more items on the scale. | Mean | Standard Deviation | Units on a scale. |
|
| OG001 | QuitGuide | Participants will be onboarded to the smartphone app "QuitGuide" (QG), and will be asked to use it for 8 weeks while they quit smoking. QuitGuide: Participants will be onboarded to the NCI smartphone app QuitGuide(QG) and will be asked to use it for 8 weeks to support them in quitting smoking. The QuitGuide app follows the US Clinical Practice Guidelines. The app is freely available on NCI's Smokefree.gov website, which is a recommended resource for treating smokers in the healthcare setting. The QuitGuide app is frequently used as a comparison app in smartphone app smoking cessation studies. It asks participants to set a quit day, track their mood and cravings, and log their cigarettes. It provides app users with guidance on quitting (i.e., "Learn to Quit" information), offers strategies to counter smoking triggers, and allows users to set reminders to stay smoke free (time and location based). |
|
|
|
| Secondary | Time Spent Applying Content | Time spent applying content will be measured with the self-report item: "During the past week, how much time did you spend applying or contemplating the content of the [Smiling Instead of Smoking app / QuitGuide app (logic-branched by treatment group)]? ______________ (in minutes, total for the week)"). | 15 participants (10 SiS-H, 5 QG) had missing data for this survey item at both time points and were excluded from analysis, which reduced the number of participants analyzed to 22 in SiS-H and 29 in QG. Another 9 participants (5 SiS-H, 4 QG) had valid survey data for this item only at one time point (either week 4 (2 weeks post-quit) or week 8 (6 weeks post-quit)), leading to reduced sample sizes at both time points. | Posted | Median | Inter-Quartile Range | Minutes | Measured at week 4 (2 weeks post-quit) and week 8 (6-weeks post-quit) |
|
|
|
|
| Secondary | Expected App Usage | A percentage based on the categorical re-coding of the actual app usage, measured in days, where YES indicates that participants used the app at least once during 6 out of the 8 weeks of the prescribed treatment weeks, and NO indicates that participants used the app less often. | Posted | Count of Participants | Participants | Assessed at end of treatment (6 weeks post-quit) |
|
|
|
|
| Secondary | Use of Smoking Cessation Strategies | Assessed using an 8-item measure in which participants rate the extent to which they agree or disagree with statements about the smoking cessation support they received and the things they did while quitting (5-point Likert scale, 1=strongly disagree, 5=strongly agree, e.g., "I used techniques to help me relax"). Higher scores indicate greater use of smoking cessation strategies. | Participants who completed this questionnaire at end-of-treatment (week 6 post-quit) only. | Posted | Mean | Standard Deviation | score on a scale | Assessed at end of treatment (6 weeks post-quit) |
|
|
|
|
| Secondary | Satisfaction With Smoking Cessation Support | As measured using the Client Satisfaction Scale (CSQ-8), an 8-item multiple choice measure that will be used to assess participants' satisfaction with the smoking cessation support they receive (e.g., "How satisfied are you with the amount of help you received?"). Scores are summed across items and range from 8 to 32, with higher scores indicating greater satisfaction. | Participants who completed this questionnaire at end-of-treatment (6 weeks post-quit). | Posted | Median | Inter-Quartile Range | score on a scale | Assessed at end of treatment (6 weeks post-quit) |
|
|
|
|
| Secondary | App Usability Rating, System Usability Scale (SUS) | As assessed via the System Usability Scale (SUS), a ten-item attitude scale giving a global view of subjective assessments of usability, adapted to include language specific to the smoking app (e.g., "I found the smoking app unnecessarily complex" 5-point Likert: 1 = strongly disagree, 5 = strongly agree). Scale scores range from 0 to 100 with greater scores indicating a more favorable perception of usability of the app. | Participants who completed this questionnaire at the post-treatment assessment (6 weeks post-quit) only. | Posted | Median | Inter-Quartile Range | score on a scale | Assessed at end of treatment (6 weeks post-quit) |
|
|
|
|
| Secondary | User Mobile Application Rating (uMARS) | User app ratings will be assessed using the Mobile Application Rating Scale user version (uMARS). The uMARS is a self-report form with 26 items that assess participants' evaluations of various app features. Dimensions of this measure include engagement (5 items), functionality (4 items), aesthetics (3 items), information quality (4 items), app subjectivity quality (4 items), and perceived impact (6 items). Items are rated on differently worded 5-point Likert scales ranging from 1 (Inadequate) to 5 (Excellent). An overall app rating score can be calculated as the mean score of the first 16 questions (range of 1-5), with higher scores meaning higher overall perceived app quality. | Those who completed the uMARS survey at the end of treatment (6 week post-quit). | Posted | Mean | Standard Deviation | Units on a scale | Assessed at end of treatment (6 weeks post-quit) |
|
|
|
|
| Secondary | Smoking Self-Efficacy Questionnaire (SEQ-12) | The Smoking Self-Efficacy Questionnaire (SEQ-12) is a two-dimensional 12-item self-report scale measuring a person's confidence in his or her ability to abstain from smoking when facing internal stimuli (e.g. feeling depressed) and external stimuli (e.g. being with smokers) on a 0-100 slider scale (i.e., 0=not at all confident that I can refrain; 100=extremely confident that I can refrain). Scale scores are created by mean scoring across items and range from 0 to 100. Higher scores indicate greater self-efficacy to abstain from smoking. | Some participants missed assessments at specific time-points or provided incomplete or invalid data on questionnaires. | Posted | Mean | Standard Deviation | score on a scale | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
|
|
|
|
| Secondary | Positive Affect - Positive and Negative Affect Schedule (PANAS) | Positive affect will be measured using the Positive and Negative Affect Schedule (PANAS). This 20-item scale asks participants to indicate how they felt in the past week, using a 5-point Likert scale ranging from 1="very slightly or not at all" to 5="extremely." Scores for 10 positive words and 10 negative words will be summed separately and will be reported as mean scores (not scale totals) ranging from 1-5, with lower scores indicating low (positive or negative) affect and higher scores indicating high (positive or negative) affect. The 10 items for POSITIVE (PA) affect are attentive, interested, alert, excited, enthusiastic, inspired, proud, determined, strong, and active. | Some participants missed assessments at specific time-points or provided incomplete or invalid data on questionnaires. | Posted | Mean | Standard Deviation | score on a scale | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
|
|
|
|
| Secondary | Negative Affect - Positive and Negative Affect Schedule (PANAS) | Negative affect will be measured using the Positive and Negative Affect Schedule (PANAS). This 20-item scale asks participants to indicate how they felt in the past week, using a 5-point Likert scale ranging from 1="very slightly or not at all" to 5="extremely." Scores for 10 positive words and 10 negative words will be summed separately and will be reported as mean scores (not scale totals) ranging from 1-5, with lower scores indicating low (positive or negative) affect and higher scores indicating high (positive or negative) affect. The 10 items for NEGATIVE (NA) affect are distressed, upset, hostile, irritable, scared, afraid, ashamed, guilty, nervous, and jittery. | Some participants missed assessments at specific time-points or provided incomplete or invalid data on questionnaires. | Posted | Mean | Standard Deviation | score on a scale | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
|
|
|
|
| Secondary | Brief Questionnaire of Smoking Urges (QSU) | Smoking urges will be assessed using the Questionnaire of Smoking Urges. This 10-item scale assesses overall nicotine dependence, craving, and smoking withdrawal symptoms. Items will be rated on a 7-point Likert-scale ranging from 1=Strongly disagree to 7=Strongly agree. We will present the mean instead of total scores for ease in interpretation, so that scale scores can range from 1.0 to 7.0, with higher scores indicating greater smoking urges. | Some participants missed assessments at specific time-points or provided incomplete or invalid data on questionnaires. | Posted | Mean | Standard Deviation | score on a scale | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
|
|
|
|
| Secondary | Attitudes Towards Smoking Scale (ATS) - Adverse Effects of Smoking Sub-scale | Smoking attitudes will be assessed using the Attitudes Towards Smoking Scale (ATS-18). The 18-item self-report ATS-18 measures attitudes towards smoking in current and former cigarette smokers. It is rated on a 5-point Likert scale, from 1="strongly disagree" to 5="strongly agree.". The ATS-18 has 3 sub-scales: Adverse effects of smoking (items 1-10), psychoactive benefits of smoking (items 11-14), and pleasure of smoking (items 15-18). To score, all items per sub-scale will be averaged to obtain a mean score within each sub-scale. For each sub-scale, higher scores indicate greater agreement with the specific attitude towards smoking. | Some participants missed assessments at specific time-points or provided incomplete or invalid data on questionnaires. | Posted | Mean | Standard Deviation | score on a scale | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
|
|
|
|
| Secondary | Attitudes Towards Smoking Scale (ATS) - Psychoactive Benefits of Smoking Sub-scale | Smoking attitudes will be assessed using the Attitudes Towards Smoking Scale (ATS-18). The 18-item self-report ATS-18 measures attitudes towards smoking in current and former cigarette smokers. It is rated on a 5-point Likert scale, from 1="strongly disagree" to 5="strongly agree.". The ATS-18 has 3 sub-scales: Adverse effects of smoking (items 1-10), psychoactive benefits of smoking (items 11-14), and pleasure of smoking (items 15-18). To score, all items per sub-scale will be averaged to obtain a mean score within each sub-scale. For each sub-scale, higher scores indicate greater agreement with the specific attitude towards smoking. | Some participants missed assessments at specific time-points or provided incomplete or invalid data on questionnaires. | Posted | Mean | Standard Deviation | Units on a scale | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
|
|
|
|
| Secondary | Attitudes Towards Smoking Scale (ATS) - Pleasure of Smoking Sub-scale | Smoking attitudes will be assessed using the Attitudes Towards Smoking Scale (ATS-18). The 18-item self-report ATS-18 measures attitudes towards smoking in current and former cigarette smokers. It is rated on a 5-point Likert scale, from 1="strongly disagree" to 5="strongly agree.". The ATS-18 has 3 sub-scales: Adverse effects of smoking (items 1-10), psychoactive benefits of smoking (items 11-14), and pleasure of smoking (items 15-18). To score, all items per sub-scale will be averaged to obtain a mean score within each sub-scale. For each sub-scale, higher scores indicate greater agreement with the specific attitude towards smoking. | Some participants missed assessments at specific time-points or provided incomplete or invalid data on questionnaires. | Posted | Mean | Standard Deviation | score on a scale | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
|
|
|
|
| Secondary | Decisional Balance Inventory (DBI) for Smoking - Negative Expectancies Sub-scale | Negative smoking expectancies will be assessed using the Decisional Balance Inventory (DBI) for Smoking Short Form. This 6-item form assesses the personal importance people place on positive and negative smoking expectancies. Items are rated on slider scales ranging from 0="not at all important" to 100="extremely important." Two sub-scale mean scores will be calculated: positive expectancies (3 items), and negative smoking expectancies (3 items). On both scales, higher scores indicate a greater importance of the smoking expectancies (positive or negative). | Some participants missed assessments at specific time-points or provided incomplete or invalid data on questionnaires. | Posted | Mean | Standard Deviation | score on a scale | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
|
|
|
|
| Secondary | Decisional Balance Inventory (DBI) for Smoking - Positive Expectancies Subscale | Positive smoking expectancies will be assessed using the Decisional Balance Inventory (DBI) for Smoking Short Form. This 6-item form assesses the personal importance people place on positive and negative smoking expectancies. Items are rated on slider scales ranging from 0="not at all important" to 100="extremely important." Two sub-scale mean scores will be calculated: positive expectancies (3 items), and negative smoking expectancies (3 items). On both scales, higher scores indicate a greater importance of the smoking expectancies (positive or negative). | Some participants missed assessments at specific time-points or provided incomplete or invalid data on questionnaires. | Posted | Mean | Standard Deviation | score on a scale | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
|
|
|
|
| Secondary | Modified Version of the Twenty Statements Test | The depth of the thought-action repertoire will be assessed using a modified version of the Open-Ended Twenty Statements Test (MOETST). The original MOETST usually starts by evoking an emotion, asks participants to name the emotion they experienced and keep it in mind, and then list all the things they would like to do 'right now'. Instead of using emotion inductions, we will ask participants to think of their upcoming quit date (at baseline) or when last using their assigned app treatment, and then fill out as many action statements as they can think of (limited to a maximum of 20) with the prompt "Instead of smoking at that moment, I could have ....". The number of actions will be summed to produce a thought-action repertoire score with a range of 0-20, with higher scores indicating a richer thought-action repertoire. | This outcome was only analyzed statistically for week 8 (6 weeks post-quit) for those who completed this questionnaire at this assessment. | Posted | Median | Inter-Quartile Range | score on a scale | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
|
|
|
|
| Other Pre-specified | 30-day Point Prevalence Abstinence (PPA) - Self-reported | Participants will be asked to report whether they were abstinent some cigarette smoking during the last 30 days (yes vs. no). Missing data will be interpreted as smoking. | Posted | Count of Participants | Participants | Measured at week 8 (6-weeks post-quit) |
|
|
|
|
| Other Pre-specified | 30-day Point Prevalence Abstinence (PPA) - Biochemically Verified | Participants will provide breath samples for expired carbon monoxide (CO; cutoff value of < 5 ppm). For CO-confirmed stated abstinence of 7 days or longer, abstinence will be verified by saliva cotinine using the NicAlert or similar test strip (based on availability; we will use test strips detecting 30ng of cotinine, where the test strip will indicate 'smoking' if the saliva content exceeds 30ng). This information will be combined with the self-reported abstinence data; reports of smoking abstinence that conflict with biochemical verification will be overridden with smoking status YES. | Posted | Count of Participants | Participants | Measured at baseline and week 20 (3 months after end of treatment) |
|
|
|
|
| Other Pre-specified | HIV Medication Adherence | HIV medication will be assessed with a 3-item medication adherence questionnaire. The three items ask about the number of days on which participants missed doses, the number of days when participants did not take medication as directed, and how well they followed directions. The answer options will be linearly transformed to 0-100 scales, averaged, and will generate a score between 0 and 100, with 0 being the lowest adherence and 100 being the highest adherence. | Some participants missed assessments at specific time-points or provided incomplete or invalid data on questionnaires. | Posted | Median | Inter-Quartile Range | score on a scale | Measured at baseline, week 4 (2 weeks post-quit), week 8 (6-weeks post-quit) |
|
|
|
|
| 0 |
| 32 |
| 0 |
| 32 |
| 0 |
| 32 |
| EG001 | QuitGuide | Participants will be onboarded to the smartphone app "QuitGuide" (QG), and will be asked to use it for 8 weeks while they quit smoking. QuitGuide: Participants will be onboarded to the NCI smartphone app QuitGuide(QG) and will be asked to use it for 8 weeks to support them in quitting smoking. The QuitGuide app follows the US Clinical Practice Guidelines. The app is freely available on NCI's Smokefree.gov website, which is a recommended resource for treating smokers in the healthcare setting. The QuitGuide app is frequently used as a comparison app in smartphone app smoking cessation studies. It asks participants to set a quit day, track their mood and cravings, and log their cigarettes. It provides app users with guidance on quitting (i.e., "Learn to Quit" information), offers strategies to counter smoking triggers, and allows users to set reminders to stay smoke free (time and location based). | 0 | 34 | 0 | 34 | 0 | 34 |
Not provided
Not provided
Not provided
| Native Hawaiian or Other Pacific Islander |
|
| Black or African American |
|
| White |
|
| More than one race |
|
| Unknown or Not Reported |
|
| Unknown or Not Reported |
|
| $75,000 - 149,999 |
|
| $150,000 or more |
|
| Rural |
|
| Week 8 (6-weeks post-quit) |
|
|
| Null hypothesis: there is no significant difference in self-reported time spent applying content between the treatment groups at endpoint (week 6 post-quit). | Wilcoxon (Mann-Whitney) | Wilcoxon Two-Sample Test, Pr > |Z|. | 0.0747 | The a priori threshold for statistical significance is alpha=0.05. | Wilcoxon test Z score | 1.7821 | 2-Sided | The effect is presented as the SiS-H group outcome compared to the QG group outcome at the end of treatment (week 6 post-quit). | Superiority |
| Week 4 (2 weeks post-quit) |
|
|
| Week 8 (6-weeks post-quit) |
|
|
| Superiority |
| Week 4 (2 weeks post-quit) |
|
|
| Week 8 (6-weeks post-quit) |
|
|
| Superiority |
| Week 4 (2 weeks post-quit) |
|
|
| Week 8 (6-weeks post-quit) |
|
|
| Superiority |
| Week 4 (2 weeks post-quit) |
|
|
| Week 8 (6-weeks post-quit) |
|
|
| Superiority |
| Week 4 (2 weeks post-quit) |
|
|
| Week 8 (6-weeks post-quit) |
|
|
| Superiority |
| Week 4 (2 weeks post-quit) |
|
|
| Week 8 (6-weeks post-quit) |
|
|
| Superiority |
| Week 4 (2 weeks post-quit) |
|
|
| Week 8 (6-weeks post-quit) |
|
|
| Superiority |
| Week 4 (2 weeks post-quit) |
|
|
| Week 8 (6-weeks post-quit) |
|
|
| Superiority |
| Week 4 (2 weeks post-quit) |
|
|
| Week 8 (6-weeks post-quit) |
|
|
| Superiority |
| Week 4 (2 weeks post-quit) |
|
|
| Week 8 (6 weeks post-quit) |
|
|
| Week 20 (3 months after end of treatment) |
|
| Week 4 (2 weeks post-quit) |
|
|
| Week 8 (6-weeks post-quit) |
|
|
| Null hypothesis: there is no significant difference in self-reported HIV medication adherence between the treatment groups at endpoint (week 6 post-quit). | Wilcoxon (Mann-Whitney) | Wilcoxon Two-Sample Test, Pr > |Z|. | 0.7770 | The a priori threshold for statistical significance is alpha=0.05. | Wilcoxon test Z score | -0.2833 | 2-Sided | The effect is presented as the SiS-H group outcome compared to the QG group outcome at the end of treatment (week 6 post-quit). | Superiority |